These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27829581)

  • 1. Enhanced Intestinal Absorption of Cholesterol along with Increased Chylomicron Remnants for De novo Progression of Coronary Stenosis.
    Masuda D; Yamashita S
    J Atheroscler Thromb; 2017 Feb; 24(2):120-122. PubMed ID: 27829581
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced Impact of Cholesterol Absorption Marker on New Atherosclerotic Lesion Progression After Coronary Intervention During Statin Therapy.
    Mori K; Ishida T; Tsuda S; Oshita T; Shinohara M; Hara T; Irino Y; Toh R; Hirata KI
    J Atheroscler Thromb; 2017 Feb; 24(2):123-132. PubMed ID: 27487947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.
    Huff MW
    Can J Clin Pharmacol; 2003; 10 Suppl A():26A-32A. PubMed ID: 14571303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chylomicron remnant model emulsions induce intracellular cholesterol accumulation and cell death due to lysosomal destabilization.
    Wakita K; Morita SY; Okamoto N; Takata E; Handa T; Nakano M
    Biochim Biophys Acta; 2015 May; 1851(5):598-604. PubMed ID: 25661161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression.
    Brener SJ; Ivanc TB; Hu T
    J Invasive Cardiol; 2008 Jun; 20(6):261-5. PubMed ID: 18523316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 7. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
    Gylling H; Miettinen TA
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do plaques rapidly progress prior to myocardial infarction? The interplay between plaque vulnerability and progression.
    Ahmadi A; Leipsic J; Blankstein R; Taylor C; Hecht H; Stone GW; Narula J
    Circ Res; 2015 Jun; 117(1):99-104. PubMed ID: 26089367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
    Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model of intestinal chylomicron over-production and ezetimibe treatment: impact on the retention of cholesterol in arterial vessels.
    Mangat R; Warnakula S; Wang Y; Russell JC; Uwiera R; Vine DF; Proctor SD
    Atheroscler Suppl; 2010 Jun; 11(1):17-24. PubMed ID: 20471328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is non-obstructive coronary artery disease clinically important?
    Sandhu A; Maddox TM
    Future Cardiol; 2014 Nov; 10(6):673-5. PubMed ID: 25495806
    [No Abstract]   [Full Text] [Related]  

  • 12. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sitosterol and sitostanol on inhibition of intestinal cholesterol absorption.
    Heinemann T; Pietruck B; Kullak-Ublick G; von Bergmann K
    Agents Actions Suppl; 1988; 26():117-22. PubMed ID: 3265272
    [No Abstract]   [Full Text] [Related]  

  • 14. Add-on ezetimibe reduces small dense low-density lipoprotein cholesterol levels without affecting absorption of eicosapentaenoic acid in patients with coronary artery disease: a pilot study.
    Kubo M; Miyoshi T; Kimura T; Noda Y; Kohno K; Nakamura K; Morita H; Ito H
    Am J Cardiovasc Drugs; 2014 Oct; 14(5):387-92. PubMed ID: 24915983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chylomicron remnant concentrations in patients with coronary artery disease.
    Orth M; Dierkes J; Luley C
    Clin Chem Lab Med; 2003 May; 41(5):652-62. PubMed ID: 12812263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plaque morphology predictors of side branch occlusion after provisional stenting in coronary bifurcation lesion: Results of optical coherence tomography bifurcation study (ORBID).
    Kini AS; Vengrenyuk Y; Pena J; Yoshimura T; Panwar SR; Motoyama S; Kezbor S; Hasan CM; Palkhiwala S; Kovacic JC; Moreno P; Baber U; Mehran R; Narula J; Sharma SK
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):259-268. PubMed ID: 27029714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of coronary calcium score in the assessment of atherosclerotic lesions in coronary arteries.
    Konieczyńska M; Tracz W; Pasowicz M; Przewłocki T
    Kardiol Pol; 2006 Oct; 64(10):1073-9; discussion 1080-1. PubMed ID: 17089239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The need for a different cholesterol lowering drug.
    Steiner G
    Can J Clin Pharmacol; 2003; 10 Suppl A():4A-6A. PubMed ID: 14571300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.